Radiotherapy for Oligometastases and Oligo-Recurrence of Bone in Prostate Cancer

<table>The overall survival curves for all patients (<svg height="11.1" id="M7" style="vertical-align:-0.17555pt" version="1.1" viewbox="0 0 42.912498 11.1" width="42.912498" xmlns="http://www.w3.org/2000/svg">
<g transform="matrix(1.25,0,0,-1.25,0,11.1)">
<g transform="translate(72,-63.12)">
<text transform="matrix(1,0,0,-1,-71.95,63.35)">
<tspan style="font-size: 12.50px; " x="0" y="0">𝑛</tspan>
<tspan style="font-size: 12.50px; " x="9.6773224" y="0">=</tspan>
<tspan style="font-size: 12.50px; " x="21.71771" y="0">3</tspan>
<tspan style="font-size: 12.50px; " x="27.969212" y="0">5</tspan>
</text>
</g>
</g>
</svg>) and those that received a total radiotherapy dose of ≥40 Gy (<svg height="10.8125" id="M8" style="vertical-align:-0.10033pt" version="1.1" viewbox="0 0 42.912498 10.8125" width="42.912498" xmlns="http://www.w3.org/2000/svg">
<g transform="matrix(1.25,0,0,-1.25,0,10.8125)">
<g transform="translate(72,-63.35)">
<text transform="matrix(1,0,0,-1,-71.95,63.5)">
<tspan style="font-size: 12.50px; " x="0" y="0">𝑛</tspan>
<tspan style="font-size: 12.50px; " x="9.6773224" y="0">=</tspan>
<tspan style="font-size: 12.50px; " x="21.71771" y="0">2</tspan>
<tspan style="font-size: 12.50px; " x="27.969212" y="0">1</tspan>
</text>
</g>
</g>
</svg>) or &lt;40 Gy (<svg height="10.8125" id="M9" style="vertical-align:-0.10033pt" version="1.1" viewbox="0 0 42.912498 10.8125" width="42.912498" xmlns="http://www.w3.org/2000/svg">
<g transform="matrix(1.25,0,0,-1.25,0,10.8125)">
<g transform="translate(72,-63.35)">
<text transform="matrix(1,0,0,-1,-71.95,63.5)">
<tspan style="font-size: 12.50px; " x="0" y="0">𝑛</tspan>
<tspan style="font-size: 12.50px; " x="9.6773224" y="0">=</tspan>
<tspan style="font-size: 12.50px; " x="21.71771" y="0">1</tspan>
<tspan style="font-size: 12.50px; " x="27.969212" y="0">4</tspan>
</text>
</g>
</g>
</svg>). RTX, radiotherapy.</table>

Pulmonary Medicine

fig1

Figure 1

Figure 1: Radiotherapy for Oligometastases and Oligo-Recurrence of Bone in Prostate Cancer 